US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Biora Therapeutics Inc (BIOR)
Biora Therapeutics Inc (BIOR) ニュース

BIOR

Biora Therapeutics (BIOR)

Biora Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:BIOR

1 2 3 4 5 6 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/15	05 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BIOR	Biora Therapeutics Inc
2024/06/11	21 : 00	GlobeNewswire Inc.	Biora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next Gen Peptide Formulation & Delivery Summit 2024	NASDAQ:BIOR	Biora Therapeutics Inc
2024/06/07	20 : 31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BIOR	Biora Therapeutics Inc
2024/06/07	05 : 33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BIOR	Biora Therapeutics Inc
2024/06/07	05 : 33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BIOR	Biora Therapeutics Inc
2024/06/07	05 : 33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BIOR	Biora Therapeutics Inc
2024/06/07	05 : 33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BIOR	Biora Therapeutics Inc
2024/06/03	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:BIOR	Biora Therapeutics Inc
2024/06/03	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:BIOR	Biora Therapeutics Inc
2024/05/21	05 : 08	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:BIOR	Biora Therapeutics Inc
2024/05/21	05 : 06	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:BIOR	Biora Therapeutics Inc
2024/05/20	21 : 00	GlobeNewswire Inc.	Biora Therapeutics Presents Clinical Data on Device Function of the NaviCap™ Platform at Digestive Disease Week 2024	NASDAQ:BIOR	Biora Therapeutics Inc
2024/05/16	05 : 05	GlobeNewswire Inc.	Biora Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results	NASDAQ:BIOR	Biora Therapeutics Inc
2024/05/07	21 : 00	GlobeNewswire Inc.	Biora Therapeutics to Report First Quarter 2024 Financial Results and Provide Corporate Update	NASDAQ:BIOR	Biora Therapeutics Inc
2024/05/06	21 : 00	GlobeNewswire Inc.	Biora Therapeutics to Present Clinical Data on Device Function of the NaviCap™ Oral Delivery Platform at Digestive Disease Week 2024	NASDAQ:BIOR	Biora Therapeutics Inc
2024/04/30	21 : 00	GlobeNewswire Inc.	Biora Therapeutics Announces Completion of Multiple-Ascending Dose (MAD) Cohorts for Clinical Trial of BT-600	NASDAQ:BIOR	Biora Therapeutics Inc
2024/04/08	21 : 00	GlobeNewswire Inc.	Biora Therapeutics Announces New Patent Covering its BioJet™ Liquid Jet Delivery Technology	NASDAQ:BIOR	Biora Therapeutics Inc
2024/04/04	21 : 00	GlobeNewswire Inc.	Biora Therapeutics Achieves Positive Interim Results for Clinical Trial of BT-600, Advancing NaviCap™ Platform Development	NASDAQ:BIOR	Biora Therapeutics Inc
2024/04/04	05 : 05	GlobeNewswire Inc.	Biora Therapeutics Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	NASDAQ:BIOR	Biora Therapeutics Inc
2024/04/01	21 : 00	GlobeNewswire Inc.	Biora Therapeutics Announces $6 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	NASDAQ:BIOR	Biora Therapeutics Inc
2024/03/27	05 : 05	GlobeNewswire Inc.	Biora Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results	NASDAQ:BIOR	Biora Therapeutics Inc
2024/03/26	20 : 21	IH Market News	U.S. Index Futures on the Rise, Oil Prices Show Stability	NASDAQ:BIOR	Biora Therapeutics Inc
2024/03/18	21 : 00	GlobeNewswire Inc.	Biora Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update	NASDAQ:BIOR	Biora Therapeutics Inc
2024/03/11	21 : 11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BIOR	Biora Therapeutics Inc
2024/03/11	21 : 00	GlobeNewswire Inc.	Biora Therapeutics Further Reduces Net Debt and Monetizes Legacy Asset	NASDAQ:BIOR	Biora Therapeutics Inc
2024/02/26	22 : 00	GlobeNewswire Inc.	Biora Therapeutics Announces Successful Completion of Single-Ascending Dose (SAD) Cohorts of Phase 1 Clinical Study of BT-600	NASDAQ:BIOR	Biora Therapeutics Inc
2024/02/16	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BIOR	Biora Therapeutics Inc
2024/02/16	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BIOR	Biora Therapeutics Inc
2024/02/15	04 : 43	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:BIOR	Biora Therapeutics Inc
2024/02/08	22 : 00	GlobeNewswire Inc.	Biora Therapeutics Announces Participation in Canaccord Genuity Inflammatory Bowel Disease Symposium	NASDAQ:BIOR	Biora Therapeutics Inc

Showing the most relevant articles for your search:NASDAQ:BIOR

1 2 3 4 5 6 次へ >>

Energy Select Sector SPDR

US Dollar vs Sterling

Health Care Select Sector

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約